Improvement of Peak Cough Flow After the Application of a Mechanical In-exsufflator in Patients With Neuromuscular Disease and Pneumonia: A Pilot Study

Objective To investigate and demonstrate persistent increase of peak cough flow after mechanical in-exsufflator application, in patients with neuromuscular diseases and pneumonia. Methods A mechanical in-exsufflator was applied with patients in an upright or semi-upright sitting position (pressure setting, +40 and −40 cmH2O; in-exsufflation times, 2–3 and 1–2 seconds, respectively). Patients underwent five cycles, with 20–30 second intervals to prevent hyperventilation. Peak cough flow without and with assistive maneuvers, was evaluated before, and 15 and 45 minutes after mechanical in-exsufflator application. Results Peak cough flow was 92.6 L/min at baseline, and 100.4 and 100.7 L/min at 15 and 45 minutes after mechanical in-exsufflator application, respectively. Assisted peak cough flow at baseline, 15 minutes, and 45 minutes after mechanical in-exsufflator application was 170.7, 179.3, and 184.1 L/min, respectively. While peak cough flow and assisted peak cough flow increased significantly at 15 minutes after mechanical in-exsufflator application compared with baseline (p=0.030 and p=0.016), no statistical difference was observed between 15 and 45 minutes. Conclusion Increased peak cough flow after mechanical in-exsufflator application persists for at least 45 minutes.

[1]  E. Bergofsky,et al.  Prolonged alteration of lung mechanics in kyphoscoliosis by positive pressure hyperinflation. , 2015, The American review of respiratory disease.

[2]  M. Chatwin,et al.  How to use a mechanical insufflator-exsufflator "cough assist machine" , 2008 .

[3]  David M. Shade,et al.  Supramaximal inflation improves lung compliance in subjects with amyotrophic lateral sclerosis. , 2006, Chest.

[4]  P. Andersen,et al.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives , 2005, European journal of neurology.

[5]  J. Bach,et al.  Effects of Mechanical Insufflation‐Exsufflation on Respiratory Parameters for Patients with Chronic Airway Secretion Encumbrance. , 2004, Chest.

[6]  J. Sancho,et al.  Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. , 2004, Chest.

[7]  A. Simonds,et al.  Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness , 2003, European Respiratory Journal.

[8]  J. Bach Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. , 2002, Chest.

[9]  G. Diette,et al.  Hospitalization in amyotrophic lateral sclerosis , 2001, Neurology.

[10]  J. Bach,et al.  Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. , 1997, Chest.

[11]  J. Bach,et al.  Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. , 1995, Archives of physical medicine and rehabilitation.

[12]  J. Bach Update and perspective on noninvasive respiratory muscle aids. Part 2: The expiratory aids. , 1994, Chest.

[13]  J. Bach Mechanical Insufflation-Exsufflation: Comparison of Peak Expiratory Flows With Manually Assisted and Unassisted Coughing Techniques , 1993 .

[14]  P. Vignos Respiratory function and pulmonary infection in Duchenne muscular dystrophy. , 1977, Israel journal of medical sciences.

[15]  S. Inkley,et al.  Pulmonary function in Duchenne muscular dystrophy related to stage of disease. , 1974, The American journal of medicine.

[16]  A. Clément,et al.  Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. , 2008, Chest.

[17]  J. Bach,et al.  Prolongation of life in Duchenne's muscular dystrophy. , 1983, Acta neurologica.